Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

2.320 USD -0.050 (-2.11%)
Streaming Delayed Price Updated: 6:10 AM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,568
Open 2.370
Bid (Size) 2.310 (1)
Ask (Size) 2.320 (13)
Prev. Close 2.370
Today's Range 2.320 - 2.370
52wk Range 1.450 - 4.200
Shares Outstanding 46,349,514
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annua
From GlobeNewswire News Releases
ADMA Biologics to Participate in Raymond James Institutional Investor Conference
From GlobeNewswire News Releases

Performance

YTD
+9.95%
+9.95%
1 Month
-5.31%
-5.31%
3 Month
+15.42%
+15.42%
6 Month
-3.33%
-3.33%
1 Year
-21.89%
-21.89%

More News

Read More
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
From GlobeNewswire News Releases
ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™
From GlobeNewswire News Releases
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook
From GlobeNewswire News Releases
Best Penny Stocks 3 Analysts Say Buy Now & 1 Has 421% Target
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™
From GlobeNewswire News Releases
ADMA Biologics Adopts Limited Duration Stockholder Rights Plan
From GlobeNewswire News Releases
Should Penny Stocks Be On Your List To Buy Now? 4 Under $3 To Watch
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
Tags national institute of health VHT Market News
From Benzinga
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.